Oncology & Cancer

New treatment approved for common skin cancer

(HealthDay)—Libtayo (cemiplimab-rwlc) injection has been approved by the U.S. Food and Drug Administration to treat advanced squamous cell carcinoma (CSCC), the agency said in a news release.

Oncology & Cancer

Lymphovascular invasion is independent predictor of survival

(HealthDay) -- In patients with invasive breast cancer, lymphovascular invasion (LVI) is a strong and independent predictor of both breast cancer-specific survival (BCSS) and distant metastasis-free survival (DMFS), according ...

Oncology & Cancer

A new therapeutic target turns the immune system against lymphoma

Non-Hodgkin's lymphoma (NHL) is a group of cancers that originate in the lymph nodes and affect white blood cells of the immune system called B cells. In NHL, B cells grow out of control and create tumors in the lymph nodes, ...

Oncology & Cancer

New clinical trial for breast and ovarian cancer vaccine

University of Colorado Hospital is one of just two academic medical centers in the nation that has enrolled breast and ovarian cancer patients to a new clinical trial of a promising cancer vaccine.

page 16 from 40